Anemia due to Chronic Kidney Disease
Understand Anemia due to Chronic Kidney Disease (CKD), also known as Anemia of CKD or Renal Anemia. Learn about diagnosis, clinical documentation, and medical coding for Anemia in CKD patients. Find information on healthcare, treatment, and management of Renal Anemia related to Chronic Kidney Disease. This resource provides insights for medical professionals, coders, and patients seeking information on Anemia associated with Chronic Kidney Disease.
Decreased red blood cell count caused by impaired erythropoietin production in damaged kidneys.
Fatigue, weakness, shortness of breath, pale skin, dizziness, headaches.
Outpatient nephrology clinics, dialysis centers, primary care offices.
ICD-10 Code Families
Complete code families applicable to D63.1
When to use each related code
| Description | When to use |
|---|---|
| Low red blood cell count caused by kidney disease. | Document when anemia is attributed to chronic kidney disease. Use additional codes to specify CKD stage if known. |
| Low red blood cell count due to iron deficiency. | Diagnose if blood tests show low iron and anemia. Common cause of anemia, can occur with or without CKD. |
| Low red blood cells due to B12 deficiency. | Diagnose when anemia is caused by vitamin B12 deficiency. Often presents with neurologic symptoms. Test B12 levels. |
Best-practice checklist
- ✓Document CKD diagnosis with ICD-10 code.
- ✓Specify anemia type (e.g., normocytic, normochromic).
- ✓Hb/Hct levels and dates documented.
- ✓Iron studies results (ferritin, transferrin saturation).
- ✓eGFR or creatinine clearance documented.
Common pitfalls to avoid
Coding anemia of CKD without specifying the type (e.g., normocytic normochromic) may lead to rejected claims or lower reimbursement.
Insufficient documentation linking anemia to CKD can cause coding errors and compliance issues with medical necessity guidelines.
Failing to code associated conditions like iron deficiency or erythropoietin resistance with renal anemia can impact DRG assignment and quality metrics.
Best-practice tips
- 01Document CKD stage and cause for ICD-10 coding accuracy.
- 02Monitor Hb levels regularly and document erythropoiesis-stimulating agent (ESA) response for CDI.
- 03Evaluate iron status and administer iron supplements per guidelines for optimal anemia management.
- 04Consider ESAs when Hb <10 g/dL, adhering to FDA guidelines and payer policies for compliance.
- 05Regularly assess for and manage ESA side effects, documenting interventions for improved patient safety.
Step-by-step checklist
- 1
1. Verify CKD diagnosis (ICD-10 N18.*) documented.
- 2
2. Confirm Hgb <13.5 g/dL (men) or <12 g/dL (women).
- 3
3. Evaluate iron studies (ferritin, transferrin saturation).
- 4
4. Assess for other anemia causes (B12, folate).
- 5
5. Document CKD-related anemia (ICD-10 D63.1)
Ready-to-paste narrative
Patient presents with symptoms consistent with anemia of chronic kidney disease (CKD), also known as renal anemia. Presenting complaints include fatigue, weakness, and shortness of breath on exertion. The patient's medical history is significant for stage [Stage of CKD] chronic kidney disease, confirmed by [Method of confirmation, e.g., estimated glomerular filtration rate (eGFR) of [eGFR value] mL/min/1.73 m2 calculated using the [eGFR equation used, e.g., CKD-EPI] equation and [Lab results supporting CKD diagnosis, e.g., elevated creatinine]]. Physical examination revealed pallor. Laboratory findings indicate a hemoglobin level of [Hemoglobin value] g/dL, which is below the normal range. Decreased erythropoietin (EPO) levels are noted, consistent with the impaired EPO production associated with CKD. Iron studies, including ferritin, transferrin saturation, and total iron binding capacity, have been ordered to assess for iron deficiency, a common comorbidity in renal anemia. The patient's current medication list includes [List current medications]. Differential diagnoses considered include iron deficiency anemia, anemia of chronic inflammation, and other causes of anemia. Based on the patient's history, physical examination, and laboratory results, the diagnosis of anemia due to chronic kidney disease is confirmed. The treatment plan includes monitoring hemoglobin levels, optimizing management of the underlying chronic kidney disease, and considering erythropoiesis-stimulating agents (ESAs) and iron supplementation if indicated, with careful consideration of potential risks and benefits. Patient education regarding the relationship between CKD and anemia, the importance of medication adherence, and potential side effects of treatment will be provided. Follow-up appointment scheduled in [Duration] to reassess hemoglobin response and adjust treatment as needed. ICD-10 code N61.1 (Anemia in chronic kidney disease) is documented for this encounter.
Common questions and answers
What are the best evidence-based strategies for managing anemia of chronic kidney disease in patients with stage 3 CKD?+
Managing anemia of chronic kidney disease (CKD) in stage 3 CKD requires a multifaceted approach. Current guidelines from KDIGO (Kidney Disease: Improving Global Outcomes) recommend evaluating for iron deficiency and treating it if present. Iron therapy can include oral iron supplements or intravenous iron if oral absorption is inadequate. Erythropoiesis-stimulating agents (ESAs) like epoetin alfa or darbepoetin alfa are typically initiated when hemoglobin levels fall below a certain threshold, usually around 10 g/dL, but the optimal target hemoglobin level remains debated and individualized patient considerations are crucial. It's essential to monitor iron parameters (ferritin, transferrin saturation) and hemoglobin levels regularly. Explore how new developments in hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) may offer alternative treatment options for managing renal anemia. Consider implementing a patient education program about anemia management to improve adherence to treatment and overall outcomes.
How can I differentiate anemia due to chronic kidney disease from other causes of anemia in a patient with declining renal function?+
Differentiating anemia of CKD from other anemias in patients with declining renal function requires a comprehensive evaluation. Anemia of CKD is typically normocytic normochromic, though iron deficiency can lead to a microcytic hypochromic picture. Begin by assessing renal function with estimated glomerular filtration rate (eGFR) and checking iron studies (ferritin, transferrin saturation, total iron binding capacity). A low reticulocyte count despite anemia can suggest reduced erythropoietin production by the failing kidneys, pointing towards renal anemia. Consider other common causes of anemia in CKD patients, such as iron deficiency anemia, anemia of chronic inflammation, and vitamin B12 or folate deficiency. Bone marrow biopsy may rarely be necessary if other causes are not apparent. Learn more about the role of newer biomarkers like hepcidin in understanding iron metabolism in CKD and how it impacts anemia management.
What are the potential complications of untreated anemia in patients with chronic kidney disease, and how can these be mitigated?+
Untreated renal anemia can lead to a cascade of complications in CKD patients. Reduced oxygen-carrying capacity contributes to fatigue, weakness, and decreased exercise tolerance, impacting quality of life. Anemia also increases the risk of cardiovascular complications, including left ventricular hypertrophy and heart failure. Cognitive impairment and depression are also more frequent in CKD patients with anemia. Effective anemia management through iron supplementation, ESAs, and potentially HIF-PHIs can mitigate these risks. Monitoring and managing blood pressure, optimizing fluid balance, and addressing other comorbid conditions are crucial for improving overall patient outcomes. Consider implementing a multidisciplinary approach involving nephrologists, cardiologists, and dieticians to provide comprehensive care for CKD patients with anemia.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.